As a new-type foreign trade service provider driven by dual engines of technology commercialization and export services, HiSiaddi has built a "1+2+3+4=1" service system, offering access to original factory supplies of DHA Powder from multiple well-known brands.
Adopting a "1+1>2" business model, HiSiaddi focuses on integrating technology transformation and export development, and continuously tracks the global DHA Powder market from both scientific research and market perspectives. Today, we conduct a professional analysis of new shifts and trends across the global DHA Powder market.
If you need more comprehensive and valuable market intelligence on DHA Powder, please contact HiSiaddi customer service.
· Accelerated substitution: The global algal DHA market reached USD 673–715 million in 2025, projected to expand to USD 1.534–1.564 billion by 2032, with a compound annual growth rate (CAGR) of 11.9%–12.7%, far outpacing fish oil DHA growth. 40% of global consumers prioritize non-animal sourced DHA, and the algal oil substitution rate in infant formula powder has exceeded 92%. Leading dairy enterprises (such as Feihe and Junlebao) saw a 40% year-on-year increase in procurement volume in 2025.
· Premium pricing for sustainability and purity: Algal oil is produced via controllable microbial fermentation, free from marine heavy metal contamination and overfishing risks, catering to vegan and allergy-prone consumer groups. EU and North American markets explicitly require raw material sustainability traceability reports, and products certified as "zero-pollution, carbon-neutral, non-GMO" command a 25%–35% price premium.
· Rising powder share: Shipments of DHA Powder (microcapsule powder) accounted for 36.8% of total algal DHA sales in 2025, up 2.6 percentage points from 2024, while oil volume dropped to 56.3%. Powder perfectly resolves pain points of oil, including easy oxidation, uneven dispersion and high transportation loss, with thermal loss rate of only 3.2% under high-temperature processing, much lower than the 18.5% oxidation rise of oil.
· Higher thresholds for purity and stability: Mainstream specifications have upgraded from 40% purity to above 45%, with top manufacturers including DSM and Cabio delivering products at 46%–48% purity. Indicator standards such as peroxide value (≤2.0–5.0 meq/kg), heavy metals (lead ≤0.1 mg/kg) and microorganisms follow the world’s strictest norms. Microcapsule encapsulation efficiency ≥95% and surface oil ≤2% have become entry requirements for high-end markets.
· Infant formula remains rigid core demand: Infant formula powder consumed 63.2% of global DHA Powder in 2025; 25% of new global food products add DHA to support brain and eye development. The EU and China mandate DHA content labeling on infant formula. In 2025, China included algal DHA as a nutritional fortifier for complementary infant foods, generating an additional annual demand of 320 tons.
· Fastest growth in functional foods: Segments including dairy drinks, baked goods and sports nutrition grew 19.7% year-on-year, accounting for 13.8% of market volume in 2025. New DHA-fortified plant milk, energy bar and fruit juice products surged 30% year-on-year in North America and Europe, marketed under selling points of "brain health, eye protection and anti-fatigue".
· Explosive growth in dietary supplements and specialized nutrition subsegments: Demand for brain health supplements for middle-aged and elderly populations (driving 30% of market growth), prenatal nutrition, pet food and Food for Special Medical Purposes (FSMP) skyrocketed. Dietary supplements captured 21.6% of total consumption in 2025, with a 14.2% year-on-year increase.
· Formation of global oligopoly pattern: International giants (DSM, Corbion, Roquette) and top Chinese manufacturers (Cabio, NHU, Zhongke Optics) occupy over 70% of global production capacity, with CR4 reaching 72%. Leading enterprises build moats through strain patents, microencapsulation technology and global certifications (FSSC 22000, FDA, Halal/Kosher), squeezing market share of small and medium-sized enterprises (SMEs).
· Clear price differentiation: Standard specifications (30%–40% purity) fell 5.3% year-on-year, with an average domestic price of CNY 1,328/kg in 2025. High-purity (≥45%), low-oxidation and customized products maintain firm pricing with a premium rate of 39.8%–62.1%.
· Supply chain centralization in China: China is the world’s largest DHA Powder producer, with 186 tons of exports in 2025 (up 9.4% year-on-year), mainly sold to Southeast Asia, the EU and North America. Supported by mature fermentation technology, 20%–30% cost advantages and sufficient production capacity, China has become the core hub of the global supply chain.
· Tightening global compliance: EU New Food Regulation (2025), US FDA nutrition labeling updates and China GB 26401-2023 standards have simultaneously raised requirements, mandating full-chain traceability, GMP production certification and full coverage of third-party test reports. Non-compliant products are banned from EU and US markets, pushing compliance costs up 15%–20% year-on-year.
1. Highest compliance thresholds: Requirements include DHA purity ≥99.5%, peroxide value ≤2.0 meq/kg and zero tolerance for heavy metals. Triple certifications for EU, China and US markets are mandatory, bringing high testing costs and long lead times.
2. Rigid supply chain dependence: Leading dairy enterprises procure over 200 tons annually per firm, requiring stable supply and consistent batch quality. Supply disruption directly halts production, while supplier switching incurs 6–12 months of certification costs.
3. Difficulty balancing price and quality: High-end markets demand premium quality, while mass-market segments enforce strict cost controls; homogeneous competition continuously squeezes profit margins.
1. Stable rigid demand plus high-end dividend: Despite declining global birth rates, penetration of premium infant formula rises. DHA acts as a core selling point, supporting a 10%–15% product price premium.
2. New incremental demand from complementary foods: Policies allowing DHA fortification in infant complementary foods unlock a hundred-billion-yuan market, creating parallel procurement demand for rice powder, fruit puree and other categories.
3. Room for customized cooperation: Joint development of exclusive specifications (e.g., DHA+ARA compound powder, high-stability microcapsule powder) with upstream suppliers builds differentiated competitive moats.
1. Severe product homogenization: Most firms purchase generic powder specifications, resulting in single terminal selling points limited to "DHA for brain health" and brutal price wars, cutting gross profit margins from 35% to below 20%.
2. Pressure of small-batch multi-SKU orders: Health brands operate extensive product lines with small single-batch orders (5–50 tons), while upstream suppliers impose high minimum order quantities (MOQs), lifting procurement costs and slowing inventory turnover.
3. Volatile end-market demand: Shifts in consumer trends and marketing campaigns cause unstable demand for middle-aged/elderly and adolescent supplements, raising inventory risks.
1. Booming niche subsegments: Emerging demand for adolescent focus support, elderly memory improvement and women’s eye protection allows differentiated formulas (DHA+lutein, DHA+vitamin D) to achieve over 30% price premiums.
2. Dividend of diversified sales channels: Cross-border e-commerce and live-stream commerce drive growth of small-batch orders, better matching flexible procurement needs.
3. High growth of compound formulations: DHA blended with ARA, vitamins or probiotics saw 22.8% year-on-year sales growth, surging demand for compound powder raw materials.
1. High processing adaptability requirements: Raw materials must withstand high temperatures (180℃+ baking), high pressure and liquid dispersion processes. Generic powder oxidizes easily, separates or impairs flavor, pushing scrap rates to 8%–15%.
2. Higher sensory experience standards: End products must be colorless, odorless and free of fishy taste; inadequate microencapsulation degrades flavor and triggers consumer complaints.
3. Cost sensitivity plus innovation pressure: Thin profit margins across food and beverage industries mean raw materials account for a large share of costs, while continuous new product launches require heavy R&D investment and high trial-and-error expenses.
1. Vast market space: The global functional food market exceeds USD 500 billion, yet penetration of DHA-fortified products remains below 10%, leaving massive growth potential.
2. Clean label trend dividend: Natural, pure and sustainable algal DHA aligns with clean label demands, serving as a core selling point to attract health-conscious consumers.
3. Cross-border co-branding opportunities: Co-branded limited-edition DHA-fortified products with internet-famous brands and wellness IPs drive explosive sales growth.
1. Weak procurement bargaining power: Low purchase volumes (1–10 tons) attract higher upstream quotations and high MOQs, pushing procurement costs 10%–20% above large manufacturers.
2. Insufficient technical and resource reserves: Lack of internal R&D, testing and compliance teams limits capacity to meet high-end market standards, weakening product competitiveness.
3. Unstable supply chains: Upstream suppliers prioritize large client orders, leaving SMEs vulnerable to supply disruptions and delayed deliveries.
1. Blue ocean niche subsegments: Pet DHA nutrition, DHA skincare and niche organic food markets face limited competition with 30%–50% price premiums.
2. Dividend of one-stop procurement services: Upstream service providers offer small-batch customization, full-category compounding and technical support, lowering SMEs’ procurement and R&D barriers.
3. Rising demand in emerging markets: Southeast Asia, the Middle East and Latin America show strong demand for mid-to-low grade DHA products with price sensitivity, matching SMEs’ product positioning.
1. Supply chain upgrade: Lock in leading suppliers and build dual-source supply systems
o Sign 3–5 year long-term pricing contracts with 2–3 globally certified leading manufacturers such as Cabio and DSM to secure production capacity and pricing, eliminating supply disruption risks.
o Establish a tiered supplier evaluation system focusing on batch consistency, test pass rates and on-time delivery rates; phase out underperforming suppliers.
2. Product differentiation: Develop exclusive specifications to strengthen core selling points
o Collaborate with upstream partners to develop exclusive microcapsule powder featuring high purity (≥48%), low oxidation (≤1.0 meq/kg) and high encapsulation rate (≥98%) tailored for premium infant formula.
o Launch DHA+ARA+lutein compound powder marketed under "dual brain & eye care", with patent filings to create exclusive selling propositions.
3. Compliance & traceability: Build a full-chain tracking system to mitigate compliance risks
o Require suppliers to provide strain traceability reports, fermentation process records and third-party test reports aligned with EU/US/China standards, enabling full traceability from raw materials to finished goods.
o Deploy a dedicated compliance team to track global policy updates and complete product certification and standard alignment in advance to avoid losses from policy changes.
1. Market segmentation: Focus on high-growth tracks to build differentiated product matrices
o Avoid competition in generic mass markets and prioritize three high-growth segments: adolescent focus support, elderly memory care and prenatal nutrition, developing targeted products for each.
o Adolescent line: DHA+PS (phosphatidylserine) for "enhanced focus and relief of mental fatigue"; Elderly line: DHA+ginkgo biloba extract for "memory improvement and age-related cognitive decline prevention".
2. Optimize procurement models: Flexible plus joint purchasing to cut costs
o Adopt small-batch multi-cycle procurement and negotiate reduced MOQs (5-ton minimum) with upstream suppliers to lower inventory backlog risks.
o Coordinate centralized purchasing with 2–3 manufacturers of similar scale to boost bargaining power and reduce procurement costs by 10%–15%.
3. Product innovation: Compound formulations and dosage form upgrades to boost added value
o Increase R&D investment to develop high-margin compound products blending DHA with vitamins, probiotics, collagen, lifting gross profit margins above 40%.
o Advance dosage form upgrades including chewable tablets, effervescent tablets and solid beverages to fit diverse consumption scenarios.
1. Raw material selection: Customize high-temperature resistant, highly dispersible microcapsule powder to cut scrap rates
o Source dedicated microcapsule powder resistant to temperatures above 180℃ with superior dispersion and zero fishy taste, using composite maltodextrin-gelatin wall materials suitable for baking and high-temperature sterilization.
o Conduct small-batch trial production testing focused on oxidation stability, dispersibility and flavor retention to select optimal raw materials.
2. Formula optimization: Streamline formulations and mask fishy taste to elevate sensory experience
o Refine product formulas by reducing easily oxidizable ingredients to extend shelf life; use natural citrus flavors (lemon, orange) to mask DHA fishiness and improve consumer acceptance.
o Build a sensory evaluation system combining professional panel testing and consumer feedback for continuous flavor and texture optimization.
3. R&D collaboration: Partner with upstream technical teams to accelerate new product launches
o Sign joint R&D agreements with raw material suppliers to share technical resources, cutting new product development cycles from 6 months to 3 months.
o Focus on clean label, low-sugar and low-fat trends to co-develop hit products including DHA-fortified plant milk, energy bars and sugar-free beverages.
1. Market positioning: Penetrate niche subsegments to avoid head-on competition
o Prioritize pet DHA nutrition, organic DHA skincare and niche organic food markets with limited competition and 30%–50% price premiums, precisely matching target customer demands.
o Pet market: Develop DHA+EPA dedicated pet powder for "fur beautification, eye protection and brain development"; Skincare market: Launch DHA moisturizing repair essence for "antioxidation and skin barrier restoration".
2. Procurement strategy: Partner with one-stop service providers to reduce overall costs
o Cooperate with service providers offering small-batch customization, full-category compounding and technical support to eliminate the need to liaise with multiple suppliers, slashing procurement management costs by 30%.
o Prioritize suppliers holding Halal, Kosher and organic certifications for direct export to emerging markets and reduced certification expenses.
3. Resource integration: Outsource technical support to compensate internal weaknesses
o Entrust third-party institutions for formula R&D, testing and compliance consulting to avoid in-house team construction, cutting R&D expenses by 50%.
o Adopt OEM production to focus on brand and channel development, outsourcing manufacturing to lower fixed asset investment risks.
If you require more authentic, objective introductions of multiple leading Chinese DHA Powder brands, please contact HiSiaddi customer service.
As a new-type foreign trade service provider driven by dual engines of technology commercialization and export services, HiSiaddi has built a "1+2+3+4=1" service system, offering access to original factory supplies of DHA Powder from multiple well-known brands.
As a research-driven foreign trade enterprise, HiSiaddi does not only promote its own factory brands like single manufacturers. Instead, we objectively analyze multiple export-competitive leading Chinese brands of DHA Powder and share their qualification certifications and market feedback, enabling purchasers to select raw materials more efficiently and reliably.
If you require more authentic, objective introductions of multiple leading Chinese DHA Powder brands, please contact HiSiaddi customer service.
· Model 1: 45% DHA Microcapsule Powder (TG type, CB-DHA45M)
· Model 2: 48% High-Purity DHA Microcapsule Powder (CB-DHA48M)
· Model 3: DHA+ARA Compound Microcapsule Powder (30%:15%, CB-DHA30ARA15)
1. Infant formula sector: Designated supplier for global top dairy enterprises, industry-leading batch consistency
o Partner clients: Danone, Nestlé, Feihe, Junlebao and other top 20 global dairy groups. Exports of infant-grade powder exceeded 1,200 tons in 2025, accounting for 75% of total export volume.
o Core feedback: Batch deviation ≤±1.0% (industry standard ±5%); oxidation retention rate ≥96% after 180℃ high-temperature processing; fish-free taste and excellent dispersibility compatible with both dry and wet mixing processes for infant formula. Zero quality complaints over 5 consecutive years.
2. Overseas functional food market: Repurchase rate above 85% in Europe, America and Southeast Asia
o European & American markets: Applied in plant milk and infant complementary foods, with 100% compatibility with clean label requirements; non-GMO and vegan-friendly, meeting EU standards limiting extra additives.
o Southeast Asian markets: Outstanding cost-performance; 45% purity powder priced 25%–30% lower than European and American brands, matching mid-to-high-end local health product markets with a 99.2% on-time delivery rate.
· International safety certifications: US FDA GRAS certification (GRN No. 289), EU Novel Food certification (EU 2017/247), FSSC 22000, cGMP certification.
· Industry standard setter: Led the drafting of China’s national standard DHA Algal Oil for Infant Formula Foods and participated in EU EFSA DHA safety assessments, with technical parameters referenced in global industry standards.
· Endorsed by authoritative institutions: Recommended by the Chinese Nutrition Society and European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); awarded the 2025 Global Microalgae DHA Technology Innovation Gold Medal.
· Model 1: 40% Economy-Grade DHA Microcapsule Powder (RK-DHA40M)
· Model 2: 45% High-Temperature Resistant DHA Microcapsule Powder (RK-DHA45MT)
· Model 3: Oil-Soluble DHA Algal Powder (RK-DHA35O)
1. Southeast Asian & Middle Eastern markets: Preferred raw material for mid-to-low grade health products and foods
o Partner clients: Nestlé Health Science Malaysia, Kalbe Indonesia, Almarai Saudi Arabia; exports exceeded 800 tons in 2025, accounting for 80% of total shipments.
o Core feedback: Strong price competitiveness (40% purity powder priced 12%–15% lower than Cabio); the high-temperature resistant RK-DHA45MT model delivers peroxide value ≤3.0 meq/kg under 190℃ baking, outperforming industry averages.
2. Overseas feed & pet food markets: Standout reputation in high-growth niche segments
o Feedback: Oil-soluble DHA algal powder suits pet food and aquafeed, with neutral odor and easy mixing, boosting pet coat health and aquaculture fry survival rates. Exports of this category rose 35% year-on-year in 2025.
· International certifications: FDA GRAS certification, EU Novel Food certification, Indonesian MUI Halal, STAR-K Kosher certification.
· Domestic credentials: National High-Tech Enterprise, awarded DHA Powder Quality Benchmark by China Food Industry Association (2024–2025).
· Client recognition: Passed supplier audits by Danone and Nestlé, named Best Cost-Performance Supplier for Southeast Asian Markets for 3 consecutive years.
· Model 1: 48% Low-Oxidation High-Purity DHA Microcapsule Powder (NH-DHA48ML)
· Model 2: 50% Ultra-High-Purity DHA Microcapsule Powder (NH-DHA50M)
· Model 3: DHA+Vitamin D Compound Powder (40%:5%, NH-DHA40D5)
1. High-end European & American health product markets: Top reputation for high purity and low oxidation
o Partner clients: GNC USA, Doppelherz Germany, Arkopharma France; exports exceeded 650 tons in 2025, accounting for 70% of total shipments.
o Core feedback: Peroxide value ≤0.8 meq/kg (industry average 2.0–5.0); 98.1% DHA activity retention after 18 months of ambient storage for 50% purity powder; ideal for premium dietary supplements and prenatal nutrition with a 20%–25% price premium over generic brands.
2. Overseas Food for Special Medical Purposes (FSMP) market: Globally recognized stability
o Feedback: Compound powder specifications meet EU FSMP standards with zero microbial detection across batches; awarded TÜV Rheinland Germany’s Special Medical Food Raw Material Safety Certification in 2025.
· Top-tier international certifications: FDA GRAS certification, EU EFSA certification, TÜV Rheinland Germany (maternal & infant friendly, special medical food) certification, ISO 9001/22000.
· Technical patents: Over 20 international patents covering high-purity Crypthecodinium cohnii fermentation and low-oxidation microencapsulation technology, globally leading process standards.
· Industry honors: Named Global High-End DHA Powder Technology Leader 2025; products featured on the recommended list of the US Nutrition Business Journal.
· Model 1: 45% Organic DHA Microcapsule Powder (HS-DHA45MO)
· Model 2: 46% Non-GMO DHA Microcapsule Powder (HS-DHA46M)
· Model 3: Native DHA Algal Powder (HS-DHA40P)
1. European & American organic food markets: Scarce resource combining organic certification and pure raw material attributes
o Partner clients: Whole Foods USA, Alnatura Germany, MUJI Japan; exports exceeded 500 tons in 2025, accounting for 85% of total shipments.
o Core feedback: China’s first algal powder brand holding dual USDA Organic and EU Organic certifications; native DHA algal powder free of solvent residues and exogenous additives, suitable for organic infant complementary foods and premium vegan nutrition with a 35%–40% price premium.
2. Japanese & South Korean markets: Strict safety standards fully satisfied
o Feedback: Heavy metal indicators (lead ≤0.008 mg/kg) outperform Japan’s Ministry of Health, Labour and Welfare standards by 50%; repurchase rate above 90% for Japanese prenatal and infant nutrition products.
· Organic certifications: USDA Organic (US), EU EC Organic, China Organic – one of very few global brands holding triple organic credentials.
· International safety certifications: FDA GRAS, EU Novel Food, FSSC 22000, cGMP, V-Label vegan certification.
· Patents & honors: Sino-US-EU-Japanese patents for algal strain genetics; awarded Global Organic Microalgae DHA Benchmark Brand 2025.
· Model 1: 38% Ultra-Economy DHA Microcapsule Powder (ZK-DHA38M)
· Model 2: 45% General-Grade DHA Microcapsule Powder (ZK-DHA45M)
· Model 3: DHA+Lutein Compound Powder (35%:2%, ZK-DHA35L2)
1. Latin American & African markets: Low-cost high-quality raw materials for mass-market products
o Partner clients: Sigma Mexico, Nestlé Brazil, Clover South Africa; exports exceeded 450 tons in 2025, accounting for 90% of total shipments.
o Core feedback: Globally lowest-priced 38% purity powder (8%–10% cheaper than Runke); baseline performance meets import standards (peroxide value ≤4.0 meq/kg), unrivaled cost-performance for local mass-market health products and fortified foods.
2. Cross-border e-commerce small-batch market: Praised for flexible supply
o Feedback: 5-ton minimum order quantity with 7-day fast delivery, matching small-batch demand from cross-border e-commerce SMEs; DHA+lutein compound powder drove 40% year-on-year sales growth in Latin American eye health supplements in 2025.
· Basic international certifications: FDA GRAS, EU Novel Food, Halal, Kosher certification, compliant with Latin American and African import standards.
· Domestic credentials: National High-Tech Enterprise, designated Feed-Grade DHA Raw Material Recommended Brand by China Ministry of Agriculture and Rural Affairs.
· Client recognition: Named Most Popular Chinese DHA Brand for Latin American Markets 2025.
表格
Brand | Key Export Regions | Core Purity Specifications | Core Selling Points | Global Recognition Rating |
Cabio | Europe, America, China | 45%–48% | Infant-grade, ultra-stable, low oxidation | ★★★★★ Global Benchmark |
Runke Bio | Southeast Asia, Middle East | 40%–45% | Cost-performance, high-temperature resistance | ★★★★ Regional Leader |
NHU | Europe, America, Japan & South Korea | 48%–50% | Ultra-high purity, low oxidation, premium positioning | ★★★★ Technology Specialist |
Huison Bio | Europe, America, Japan & South Korea | 45%–46% | Organic, ultra-pure, superior safety | ★★★★ Organic Benchmark |
Zhongke Optics | Latin America, Africa | 38%–45% | Ultra-low price, flexible small-batch supply | ★★★ Emerging Cost-Performance Player |
If you require more authentic, objective introductions of multiple leading Chinese DHA Powder brands, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
